论文部分内容阅读
[目的]探讨CAG方案(阿糖胞苷和阿克拉霉素联合粒细胞集落刺激因子)对老年急性髓细胞白血病(AML)初治患者的疗效和不良反应。[方法]对22例60岁以上初治老年AML患者,均采用CAG方案治疗。[结果]完全缓解8例,部分缓解7例,未缓解7例;完全缓解率36.36%,总有效率68.18%。[结论]CAG方案对于初治老年AML患者具有较高的缓解率,且不良反应较轻,绝大多数患者耐受性良好。
[Objective] To investigate the efficacy and side effects of CAG regimen (cytarabine and aclacinomycin combined with granulocyte colony-stimulating factor) in the treatment of patients with senile acute myeloid leukemia (AML). [Method] Twenty-two elderly AML patients over 60 years of age were treated with CAG regimen. [Results] 8 cases were completely relieved, 7 cases partially relieved, 7 cases were not relieved. The complete remission rate was 36.36% and the total effective rate was 68.18%. [Conclusion] The CAG regimen has a high remission rate for newly diagnosed AML patients with mild adverse reactions and the majority of patients are well tolerated.